http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RS-52851-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 2010-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e29cb20895505cd1876a596fecc2a4d
publicationDate 2013-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RS-52851-B
titleOfInvention CYCLOPROPYL AMID DERIVATIVES AIMING THE HISTAMINE H3 RECEPTOR
abstract Compound of formula I, or enantiomers or diastereomers thereof, or pharmaceutically acceptable salts of formula I, or enantiomers or diastereomers thereof, or mixtures thereof: wherein: R 1 is aryl, heteroaryl, -C 1 -C 6 alkyl-C 1 -C 3 alkoxy, -C 1 -C 6 alkyl- hydroxy, -C1-C6alkyl-C (= O) -NR11R12, -S (= O) 2NR11R12, heterocycle, cyano, haloalkyl, -C (= O) NR11R12, alkoxy, or halogen, R2 is C1-C6alkyl or C3- R3, R4, R5, R6, R7, R8, R9, and R10 are each independently selected from H and C1-C3alkyl; iR11 and R12 are each independently selected from H, -C1-C6alkyl, -C1-C3alkyl-C1-C3alkoxy, 5-membered heterocycloalkyl containing at least one heteroatom selected from O and N, 6-membered heterocycloalkyl containing at least one heteroatom selected from O and N, - (C1-C3alkyl) - (5-membered heteroaryl containing at least one heteroatom selected from O and N), - (C1-C3alkyl) - (6-membered heteroaryl containing at least one heteroatom selected from O and N) ), haloalkyl, or R 11, R 12 and the nitrogen to which they are attached combine to form a heterocycloalkyl selected from pyrrolidinyl, morpholinyl, piperidinyl, and piperazinyl, wherein said heterocycloalkyl is optionally substituted with at least one substituent selected from -C 1 -C 3 alkyl and -C 1 -C6alkyl-C1-C3alkoxy; and provided that: i) at least one of R 3, R 4, R 5, R 6, R 7, R 8, R 9, and R 10 is C 1 -C 3 alkyl, ii) formula I never R 1 is a -C (= O) NR 11 R 12 group meta-attached to phenyl, R2 is isopropyl, and R11 and R12 are H; iiii) formula I is not in the cis configuration on cyclopropane. The application contains 14 more claims.
priorityDate 2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410531710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21450380

Total number of triples: 40.